首页 > 最新文献

JAMA Network Open最新文献

英文 中文
Pressure-Mediated Biofeedback With Pelvic Floor Muscle Training for Urinary Incontinence: A Randomized Clinical Trial. 压力介导生物反馈配合盆底肌肉训练治疗尿失禁:随机临床试验
IF 10.5 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-04 DOI: 10.1001/jamanetworkopen.2024.42925
Xiuqi Wang, Jin Qiu, Dan Li, Zhongmin Wang, Yanjing Yang, Guorong Fan, Xiaoyan Mao, Jiandi Wang, Shan Gao, Xihui Zhu, Tao Xu, Zhijing Sun

Importance: Supervised pelvic floor muscle training (PFMT) has been recommended as the first-line treatment for women with stress urinary incontinence (SUI), but more evidence on whether adjunctive methods would provide additional benefits is needed.

Objective: To compare the efficacy of PFMT with or without a home-based pressure-mediated biofeedback (BF) device.

Design, setting, and participants: This multicenter assessor-blinded randomized clinical trial was conducted in the obstetric clinics of 5 participating tertiary hospitals in China. Participants included eligible women with new-onset postpartum SUI who were enrolled from March 28, 2022, to October 13, 2023.

Intervention: All participants received 3 months of supervised PFMT and were randomized to either the intervention (PFMT with a home-based pressure-mediated BF device) or the control group (home-based PFMT).

Main outcome and measures: The primary outcome was the severity of urinary incontinence evaluated by the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form after 3 months of supervised PFMT. The secondary outcomes included the cure and improvement rates, PFM strength, quality of life, self-efficacy, and adherence.

Results: A total of 452 participants (median age, 34 [IQR, 31-36] years; median body mass index [calculated as the weight in kilograms divided by the height in square meters], 23.71 [IQR, 21.37-25.97]; median time since delivery, 50 [IQR, 43-61] days) were included in the analysis, with 223 in the intervention group and 229 in the control group. Compared with the control group, the intervention group achieved a significantly greater reduction in incontinence severity (median, 3.00 [IQR, 1.00-6.00] vs 2.00 [IQR, 0-4.00] points; z = -3.05; P = .002), significantly increased cure rate (45 of 223 [20.2%] vs 20 of 229 [8.7%]; z = 12.02; P = .001) and improvement (132 of 223 [59.2%] vs 102 of 229 [44.5%]; z = 9.71; P = .002), significantly greater pelvic floor muscle strength (median, 26.00 [IQR, 17.00-38.00] vs 21.00 [IQR, 13.50-33.50] cm H2O; z = -2.28; P = .02), and a significantly greater correlation between subjective and objective adherence (r = 0.825 vs r = 0.627).

Conclusion and relevance: In this randomized clinical trial, the efficacy of pressure-mediated BF combined with PFMT was superior to that of PFMT alone. These findings support the use of pressure-mediated BF devices for improving treatment outcomes for patients with SUI.

Trial registration: ClinicalTrials.gov Identifier: NCT05115864.

重要性:有监督的盆底肌肉训练(PFMT)已被推荐为压力性尿失禁(SUI)女性的一线治疗方法,但还需要更多证据来证明辅助方法是否能带来额外的益处:目的:比较在使用或不使用家庭压力介导生物反馈(BF)装置的情况下进行压力性尿失禁治疗的疗效:这项多中心评估者盲法随机临床试验在中国 5 家参与试验的三级医院的产科门诊进行。参与者包括 2022 年 3 月 28 日至 2023 年 10 月 13 日期间入组的符合条件的新发产后 SUI 妇女:所有参与者均接受了3个月的PFMT指导,并被随机分配到干预组(使用家用压力介导BF装置进行PFMT)或对照组(家用PFMT):主要结果:主要结果是尿失禁的严重程度,采用国际尿失禁咨询问卷-尿失禁简表进行评估。次要结果包括治愈率和改善率、PFM强度、生活质量、自我效能感和坚持率:共有 452 名参与者(年龄中位数为 34 [IQR,31-36]岁;体重指数中位数[以体重(公斤)除以身高(平方米)计算]为 23.71 [IQR,21.37-25.97];产后时间中位数为 50 [IQR,43-61]天)参与了分析,其中干预组 223 人,对照组 229 人。与对照组相比,干预组尿失禁严重程度明显降低(中位数,3.00 [IQR, 1.00-6.00] vs 2.00 [IQR, 0-4.00] 点;z = -3.05;P = .002),治愈率明显提高(223 例中的 45 例 [20.2%] vs 229 例中的 20 例 [8.7%];z = 12.02;P = .001),情况有所改善(223 例中的 132 例 [59.2%]对 229 例中的 102 例[44.5%];z = 9.71;P = .002),盆底肌肉力量显著增强(中位数,26.00 [IQR, 17.00-38.00] 对 21.00 [IQR, 13.50-33.50] cm H2O;z = -2.28;P = .02),主观和客观依从性之间的相关性显著增强(r = 0.825 对 r = 0.627):在这项随机临床试验中,压力介导的 BF 结合 PFMT 的疗效优于单独使用 PFMT。这些研究结果支持使用压力介导 BF 设备改善 SUI 患者的治疗效果:试验注册:ClinicalTrials.gov Identifier:试验注册:ClinicalTrials.gov Identifier:NCT05115864。
{"title":"Pressure-Mediated Biofeedback With Pelvic Floor Muscle Training for Urinary Incontinence: A Randomized Clinical Trial.","authors":"Xiuqi Wang, Jin Qiu, Dan Li, Zhongmin Wang, Yanjing Yang, Guorong Fan, Xiaoyan Mao, Jiandi Wang, Shan Gao, Xihui Zhu, Tao Xu, Zhijing Sun","doi":"10.1001/jamanetworkopen.2024.42925","DOIUrl":"10.1001/jamanetworkopen.2024.42925","url":null,"abstract":"<p><strong>Importance: </strong>Supervised pelvic floor muscle training (PFMT) has been recommended as the first-line treatment for women with stress urinary incontinence (SUI), but more evidence on whether adjunctive methods would provide additional benefits is needed.</p><p><strong>Objective: </strong>To compare the efficacy of PFMT with or without a home-based pressure-mediated biofeedback (BF) device.</p><p><strong>Design, setting, and participants: </strong>This multicenter assessor-blinded randomized clinical trial was conducted in the obstetric clinics of 5 participating tertiary hospitals in China. Participants included eligible women with new-onset postpartum SUI who were enrolled from March 28, 2022, to October 13, 2023.</p><p><strong>Intervention: </strong>All participants received 3 months of supervised PFMT and were randomized to either the intervention (PFMT with a home-based pressure-mediated BF device) or the control group (home-based PFMT).</p><p><strong>Main outcome and measures: </strong>The primary outcome was the severity of urinary incontinence evaluated by the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form after 3 months of supervised PFMT. The secondary outcomes included the cure and improvement rates, PFM strength, quality of life, self-efficacy, and adherence.</p><p><strong>Results: </strong>A total of 452 participants (median age, 34 [IQR, 31-36] years; median body mass index [calculated as the weight in kilograms divided by the height in square meters], 23.71 [IQR, 21.37-25.97]; median time since delivery, 50 [IQR, 43-61] days) were included in the analysis, with 223 in the intervention group and 229 in the control group. Compared with the control group, the intervention group achieved a significantly greater reduction in incontinence severity (median, 3.00 [IQR, 1.00-6.00] vs 2.00 [IQR, 0-4.00] points; z = -3.05; P = .002), significantly increased cure rate (45 of 223 [20.2%] vs 20 of 229 [8.7%]; z = 12.02; P = .001) and improvement (132 of 223 [59.2%] vs 102 of 229 [44.5%]; z = 9.71; P = .002), significantly greater pelvic floor muscle strength (median, 26.00 [IQR, 17.00-38.00] vs 21.00 [IQR, 13.50-33.50] cm H2O; z = -2.28; P = .02), and a significantly greater correlation between subjective and objective adherence (r = 0.825 vs r = 0.627).</p><p><strong>Conclusion and relevance: </strong>In this randomized clinical trial, the efficacy of pressure-mediated BF combined with PFMT was superior to that of PFMT alone. These findings support the use of pressure-mediated BF devices for improving treatment outcomes for patients with SUI.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov Identifier: NCT05115864.</p>","PeriodicalId":14694,"journal":{"name":"JAMA Network Open","volume":"7 11","pages":"e2442925"},"PeriodicalIF":10.5,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11539013/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142583207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regional Disparities, Economic Development, and Neonatal Mortality and Hospital Delivery in China. 中国的地区差异、经济发展与新生儿死亡率和住院分娩。
IF 10.5 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-04 DOI: 10.1001/jamanetworkopen.2024.43423
Hai Fang, Haijun Zhang, Arturo Vargas Bustamante, Shusheng Luo, Xi Chen, Yanqiu Gao, Jianmeng Liu

Importance: A negative association between neonatal mortality and hospital delivery has been found in some low- and lower-middle-income countries but not in rural settings characterized by poor quality of maternal and child health care.

Objective: To examine the association between neonatal mortality and hospital delivery in China across urban and rural regions, regional disparities, and varying levels of economic development.

Design, setting, and participants: This retrospective cohort study used county-level data from 2008 to 2020 from the National Maternal & Child Health Statistics across mainland China. Statistical analysis was conducted from March to December 2023.

Exposures: Since 2008, China has strategically leveraged hospital deliveries with national subsidies to diminish neonatal mortality, particularly in rural areas.

Main outcomes and measures: Neonatal mortality and hospital delivery rates were calculated, and their association was estimated using multivariable fixed-effects linear models of county-level cohort data to adjust for time-invariant differences across counties and controls for gross domestic product (GDP) per capita, women's years of education, hospital beds, and health workers.

Results: The analysis included data from 2930 counties, with 198.7 million live births across 36 255 county-year records between 2008 and 2020. The mean (SD) neonatal mortality rate per 1000 live births decreased in rural areas from 12.3 (7.5) in 2008 to 3.9 (2.7) in 2020 and decreased in urban areas from 5.0 (3.1) in 2008 to 2.0 (1.3) in 2020. Hospital delivery rates increased in rural areas from a mean (SD) of 93.4% (11.8%) in 2008 to 99.9% (0.6%) in 2020 and increased in urban areas from 97.7% (6.1%) in 2008 to 100.0% (0.1%) in 2020. In rural areas, an increase of 10 percentage points in hospital deliveries was associated with a neonatal mortality rate of -1.4 (95% CI, -1.9 to -1.0; P < .001) per 1000 live births, whereas this negative association was not observed in urban areas. When the analysis was stratified by regions and incomes, the negative association became considerably stronger in the western and central regions of China, as well as in counties with lower GDP per capita.

Conclusions and relevance: This cohort study of more than 2900 counties in China suggests that an increase in hospital deliveries was associated with reduced neonatal mortality in rural and economically underdeveloped areas in China. To further reduce neonatal mortality and improve newborn health, it is imperative to increase the accessibility of hospital delivery services.

重要性:在一些低收入和中低收入国家,新生儿死亡率与住院分娩之间存在负相关,但在妇幼保健质量较差的农村地区,这种负相关并不存在:研究中国不同城乡地区、地区差异和不同经济发展水平的新生儿死亡率与住院分娩之间的关系:这项回顾性队列研究使用了中国大陆地区 2008 年至 2020 年全国妇幼卫生统计数据中的县级数据。统计分析于 2023 年 3 月至 12 月进行:自 2008 年以来,中国利用国家补贴对住院分娩进行了战略倾斜,以降低新生儿死亡率,尤其是农村地区的新生儿死亡率:计算了新生儿死亡率和住院分娩率,并使用县级队列数据的多变量固定效应线性模型估算了它们之间的关联,以调整各县之间的时间变量差异,并控制人均国内生产总值(GDP)、妇女受教育年限、医院床位和卫生工作者:分析包括来自 2930 个县的数据,2008 年至 2020 年间,36 255 个县年记录中的活产儿数量为 1.987 亿。农村地区每 1000 例活产的新生儿平均死亡率(标度)从 2008 年的 12.3(7.5)下降到 2020 年的 3.9(2.7),城市地区从 2008 年的 5.0(3.1)下降到 2020 年的 2.0(1.3)。农村地区的住院分娩率从 2008 年的平均值(标度)93.4%(11.8%)上升到 2020 年的 99.9%(0.6%),城市地区的住院分娩率从 2008 年的 97.7%(6.1%)上升到 2020 年的 100.0%(0.1%)。在农村地区,住院分娩率每增加 10 个百分点,新生儿死亡率为-1.4(95% CI,-1.9 至-1.0;P 结论及意义:这项对中国 2900 多个县进行的队列研究表明,在中国农村和经济欠发达地区,住院分娩率的提高与新生儿死亡率的降低有关。为进一步降低新生儿死亡率,改善新生儿健康状况,必须提高住院分娩服务的可及性。
{"title":"Regional Disparities, Economic Development, and Neonatal Mortality and Hospital Delivery in China.","authors":"Hai Fang, Haijun Zhang, Arturo Vargas Bustamante, Shusheng Luo, Xi Chen, Yanqiu Gao, Jianmeng Liu","doi":"10.1001/jamanetworkopen.2024.43423","DOIUrl":"10.1001/jamanetworkopen.2024.43423","url":null,"abstract":"<p><strong>Importance: </strong>A negative association between neonatal mortality and hospital delivery has been found in some low- and lower-middle-income countries but not in rural settings characterized by poor quality of maternal and child health care.</p><p><strong>Objective: </strong>To examine the association between neonatal mortality and hospital delivery in China across urban and rural regions, regional disparities, and varying levels of economic development.</p><p><strong>Design, setting, and participants: </strong>This retrospective cohort study used county-level data from 2008 to 2020 from the National Maternal & Child Health Statistics across mainland China. Statistical analysis was conducted from March to December 2023.</p><p><strong>Exposures: </strong>Since 2008, China has strategically leveraged hospital deliveries with national subsidies to diminish neonatal mortality, particularly in rural areas.</p><p><strong>Main outcomes and measures: </strong>Neonatal mortality and hospital delivery rates were calculated, and their association was estimated using multivariable fixed-effects linear models of county-level cohort data to adjust for time-invariant differences across counties and controls for gross domestic product (GDP) per capita, women's years of education, hospital beds, and health workers.</p><p><strong>Results: </strong>The analysis included data from 2930 counties, with 198.7 million live births across 36 255 county-year records between 2008 and 2020. The mean (SD) neonatal mortality rate per 1000 live births decreased in rural areas from 12.3 (7.5) in 2008 to 3.9 (2.7) in 2020 and decreased in urban areas from 5.0 (3.1) in 2008 to 2.0 (1.3) in 2020. Hospital delivery rates increased in rural areas from a mean (SD) of 93.4% (11.8%) in 2008 to 99.9% (0.6%) in 2020 and increased in urban areas from 97.7% (6.1%) in 2008 to 100.0% (0.1%) in 2020. In rural areas, an increase of 10 percentage points in hospital deliveries was associated with a neonatal mortality rate of -1.4 (95% CI, -1.9 to -1.0; P < .001) per 1000 live births, whereas this negative association was not observed in urban areas. When the analysis was stratified by regions and incomes, the negative association became considerably stronger in the western and central regions of China, as well as in counties with lower GDP per capita.</p><p><strong>Conclusions and relevance: </strong>This cohort study of more than 2900 counties in China suggests that an increase in hospital deliveries was associated with reduced neonatal mortality in rural and economically underdeveloped areas in China. To further reduce neonatal mortality and improve newborn health, it is imperative to increase the accessibility of hospital delivery services.</p>","PeriodicalId":14694,"journal":{"name":"JAMA Network Open","volume":"7 11","pages":"e2443423"},"PeriodicalIF":10.5,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11541646/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142583209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety of Simultaneous vs Sequential mRNA COVID-19 and Inactivated Influenza Vaccines: A Randomized Clinical Trial. 同时接种与连续接种 mRNA COVID-19 和灭活流感疫苗的安全性:随机临床试验。
IF 10.5 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-04 DOI: 10.1001/jamanetworkopen.2024.43166
Emmanuel B Walter, Elizabeth P Schlaudecker, Kawsar R Talaat, Wes Rountree, Karen R Broder, Jonathan Duffy, Lisa A Grohskopf, Marek S Poniewierski, Rachel L Spreng, Mary A Staat, Rediet Tekalign, Oidda Museru, Anju Goel, Grace N Davis, Kenneth E Schmader
<p><strong>Importance: </strong>Limited randomized clinical trial data exist on the safety of simultaneous administration of COVID-19 and influenza vaccines.</p><p><strong>Objective: </strong>To compare the reactogenicity, safety, and changes in health-related quality of life (HRQOL) after simultaneous vs sequential receipt of messenger RNA (mRNA) COVID-19 vaccine and quadrivalent inactivated influenza vaccine (IIV4).</p><p><strong>Design, setting, and participants: </strong>This randomized, placebo-controlled clinical trial was conducted between October 8, 2021, and June 14, 2023, at 3 US sites. Participants were nonpregnant persons aged 5 years or older with the intention of receiving both influenza and mRNA COVID-19 vaccines.</p><p><strong>Interventions: </strong>Intramuscular administration in opposite arms of either IIV4 or saline placebo simultaneously with mRNA COVID-19 vaccine at visit 1. Those who received placebo at visit 1 received IIV4 and those who received IIV4 at visit 1 received placebo 1 to 2 weeks later at visit 2.</p><p><strong>Main outcomes and measures: </strong>The primary composite reactogenicity outcome was the proportion of participants with fever, chills, myalgia, and/or arthralgia of moderate or greater severity within 7 days after vaccination visits 1 and/or 2, using a 10% noninferiority margin. Secondary outcomes were solicited reactogenicity events and unsolicited adverse events (AEs) for 7 days after each visit separately and HRQOL after visit 1, assessed by the EuroQol 5-Dimension 5-Level (EQ-5D-5L) Index. Serious AEs (SAEs) and AEs of special interest (AESIs) were assessed for 121 days. Outcomes were compared between groups.</p><p><strong>Results: </strong>A total of 335 persons (mean [SD] age, 33.4 [15.1] years) were randomized (169 to the simultaneous group and 166 to the sequential group); 211 (63.0%) were female, and 255 (76.1%) received bivalent BNT162b2 mRNA COVID-19 vaccine. The proportion with the primary composite reactogenicity outcome in the simultaneous group (25.6% [n = 43]) was noninferior to the proportion in the sequential group (31.3% [n = 52]) (site-adjusted difference, -5.6 percentage points [pp]; 95% CI, -15.2 to 4.0 pp). Respective proportions in each group were similar after each visit separately (visit 1, 40 [23.8%] vs 47 [28.3%]; visit 2, 5 [3.0%] vs 9 [5.4%]). No significant group differences in participants with AEs (21 [12.4%] vs 16 [9.6%]), SAEs (1 [0.6%] vs 1 [0.6%]), and AESIs (19 [11.2%] vs 9 [5.4%]) were observed in the simultaneous vs sequential groups, respectively. Among participants with severe reactogenicity, the mean (SD) EQ-5D-5L Index score decreased from 0.92 (0.08) to 0.92 (0.09) prevaccination to 0.81 (0.09) to 0.82 (0.12) postvaccination.</p><p><strong>Conclusions and relevance: </strong>In this randomized clinical trial assessing simultaneous vs sequential administration of mRNA COVID-19 and IIV4 vaccines, reactogenicity was comparable in both groups. These findings sup
重要性:有关同时接种 COVID-19 和流感疫苗安全性的随机临床试验数据有限:目的:比较同时接种与依次接种信使核糖核酸(mRNA)COVID-19疫苗和四价灭活流感疫苗(IIV4)后的致反应性、安全性和健康相关生活质量(HRQOL)的变化:这项随机、安慰剂对照临床试验于 2021 年 10 月 8 日至 2023 年 6 月 14 日期间在美国的 3 个地点进行。参与者为 5 岁或以上的非孕妇,他们打算同时接种流感疫苗和 mRNA COVID-19 疫苗:干预措施:在第 1 次就诊时,对侧手臂肌肉注射 IIV4 或生理盐水安慰剂,同时接种 mRNA COVID-19 疫苗。在第 1 次接种安慰剂的患者接种 IIV4,在第 1 次接种 IIV4 的患者在 1 到 2 周后的第 2 次接种安慰剂:主要复合致反应性结果是接种第 1 和/或第 2 次后 7 天内出现中度或更严重发热、寒战、肌痛和/或关节痛的参与者比例,采用 10% 的非劣效差。次要结果为每次就诊后 7 天内的主动反应性事件和主动不良事件 (AE),以及就诊 1 后的 HRQOL(由 EuroQol 5-Dimension 5-Level (EQ-5D-5L) 指数评估)。严重不良反应(SAEs)和特殊不良反应(AESIs)的评估时间为121天。结果在各组之间进行了比较:共有 335 人(平均 [SD] 年龄为 33.4 [15.1] 岁)被随机分组(169 人被分到同步组,166 人被分到顺序组);211 人(63.0%)为女性,255 人(76.1%)接种了二价 BNT162b2 mRNA COVID-19 疫苗。同时接种组的主要复合反应性结果比例(25.6% [n = 43])不劣于顺序接种组(31.3% [n = 52])(部位调整后差异为-5.6个百分点[pp];95% CI为-15.2至4.0个百分点)。各组在每次就诊后的比例相似(第1次就诊,40 [23.8%] vs 47 [28.3%];第2次就诊,5 [3.0%] vs 9 [5.4%])。同时用药组与连续用药组在AEs(21 [12.4%] vs 16 [9.6%])、SAEs(1 [0.6%] vs 1 [0.6%])和AESIs(19 [11.2%] vs 9 [5.4%])方面分别没有观察到明显的组间差异。在出现严重反应性的参与者中,EQ-5D-5L 指数的平均值(标度)从接种前的 0.92 (0.08) 降至 0.92 (0.09),而接种后则从 0.81 (0.09) 降至 0.82 (0.12):在这项评估同时接种 mRNA COVID-19 和 IIV4 疫苗的随机临床试验中,两组的致反应性相当。这些发现支持同时接种这些疫苗的方案:试验注册:ClinicalTrials.gov Identifier:试验注册:ClinicalTrials.gov Identifier:NCT05028361。
{"title":"Safety of Simultaneous vs Sequential mRNA COVID-19 and Inactivated Influenza Vaccines: A Randomized Clinical Trial.","authors":"Emmanuel B Walter, Elizabeth P Schlaudecker, Kawsar R Talaat, Wes Rountree, Karen R Broder, Jonathan Duffy, Lisa A Grohskopf, Marek S Poniewierski, Rachel L Spreng, Mary A Staat, Rediet Tekalign, Oidda Museru, Anju Goel, Grace N Davis, Kenneth E Schmader","doi":"10.1001/jamanetworkopen.2024.43166","DOIUrl":"10.1001/jamanetworkopen.2024.43166","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Importance: &lt;/strong&gt;Limited randomized clinical trial data exist on the safety of simultaneous administration of COVID-19 and influenza vaccines.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To compare the reactogenicity, safety, and changes in health-related quality of life (HRQOL) after simultaneous vs sequential receipt of messenger RNA (mRNA) COVID-19 vaccine and quadrivalent inactivated influenza vaccine (IIV4).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design, setting, and participants: &lt;/strong&gt;This randomized, placebo-controlled clinical trial was conducted between October 8, 2021, and June 14, 2023, at 3 US sites. Participants were nonpregnant persons aged 5 years or older with the intention of receiving both influenza and mRNA COVID-19 vaccines.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Interventions: &lt;/strong&gt;Intramuscular administration in opposite arms of either IIV4 or saline placebo simultaneously with mRNA COVID-19 vaccine at visit 1. Those who received placebo at visit 1 received IIV4 and those who received IIV4 at visit 1 received placebo 1 to 2 weeks later at visit 2.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main outcomes and measures: &lt;/strong&gt;The primary composite reactogenicity outcome was the proportion of participants with fever, chills, myalgia, and/or arthralgia of moderate or greater severity within 7 days after vaccination visits 1 and/or 2, using a 10% noninferiority margin. Secondary outcomes were solicited reactogenicity events and unsolicited adverse events (AEs) for 7 days after each visit separately and HRQOL after visit 1, assessed by the EuroQol 5-Dimension 5-Level (EQ-5D-5L) Index. Serious AEs (SAEs) and AEs of special interest (AESIs) were assessed for 121 days. Outcomes were compared between groups.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 335 persons (mean [SD] age, 33.4 [15.1] years) were randomized (169 to the simultaneous group and 166 to the sequential group); 211 (63.0%) were female, and 255 (76.1%) received bivalent BNT162b2 mRNA COVID-19 vaccine. The proportion with the primary composite reactogenicity outcome in the simultaneous group (25.6% [n = 43]) was noninferior to the proportion in the sequential group (31.3% [n = 52]) (site-adjusted difference, -5.6 percentage points [pp]; 95% CI, -15.2 to 4.0 pp). Respective proportions in each group were similar after each visit separately (visit 1, 40 [23.8%] vs 47 [28.3%]; visit 2, 5 [3.0%] vs 9 [5.4%]). No significant group differences in participants with AEs (21 [12.4%] vs 16 [9.6%]), SAEs (1 [0.6%] vs 1 [0.6%]), and AESIs (19 [11.2%] vs 9 [5.4%]) were observed in the simultaneous vs sequential groups, respectively. Among participants with severe reactogenicity, the mean (SD) EQ-5D-5L Index score decreased from 0.92 (0.08) to 0.92 (0.09) prevaccination to 0.81 (0.09) to 0.82 (0.12) postvaccination.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions and relevance: &lt;/strong&gt;In this randomized clinical trial assessing simultaneous vs sequential administration of mRNA COVID-19 and IIV4 vaccines, reactogenicity was comparable in both groups. These findings sup","PeriodicalId":14694,"journal":{"name":"JAMA Network Open","volume":"7 11","pages":"e2443166"},"PeriodicalIF":10.5,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11541642/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142583216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tobacco Quitline Retreatment Interventions Among Adults With Socioeconomic Disadvantage: A Factorial Randomized Clinical Trial. 对社会经济状况不佳的成年人进行戒烟热线再治疗干预:一项因子随机临床试验。
IF 10.5 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-04 DOI: 10.1001/jamanetworkopen.2024.43044
Jesse T Kaye, Julie A Kirsch, Daniel M Bolt, Kathleen H Kobinsky, Katrina A Vickerman, Kristina Mullis, David L Fraser, Timothy B Baker, Michael C Fiore, Danielle E McCarthy
<p><strong>Importance: </strong>A single round of standard tobacco quitline treatment may not be sufficient to sustain abstinence, particularly among people experiencing socioeconomic disadvantage. Adaptive retreatment may help more individuals with socioeconomic disadvantage achieve abstinence and reduce disparities in smoking cessation outcomes.</p><p><strong>Objective: </strong>To evaluate 4 evidence-based strategies for adults with limited education, no insurance, or Medicaid eligibility who continued smoking after quitline treatment.</p><p><strong>Design, setting, and participants: </strong>A factorial randomized clinical trial with 4 factors adapting quitline strategies was conducted for participants enrolled from June 7, 2018, to January 25, 2023, with 6-month follow-up. Adults using the Wisconsin Tobacco Quit Line who were smoking cigarettes 3 to 6 months after prior quitline treatment who were uninsured, Medicaid insured, or had no more than a high school education were included.</p><p><strong>Interventions: </strong>Quitline retreatment strategies were (1) increased counseling intensity (4 calls vs 1 call), (2) increased nicotine replacement therapy intensity (4 weeks of combination nicotine patch plus nicotine lozenge vs 2 weeks of nicotine patch), (3) text-message support (National Cancer Institute SmokefreeTXT program vs none), and (4) financial incentives for engagement in counseling and SmokefreeTXT ($30/call and/or 6-week SmokefreeTXT retention vs no incentives).</p><p><strong>Main outcomes and measures: </strong>Primary outcome was 7-day point-prevalence biochemically confirmed abstinence 26 weeks after the target quit day. Intention-to-treat analysis was performed.</p><p><strong>Results: </strong>Of 6019 people assessed for eligibility, 1316 (21.9%) participants were randomized (mean [SD] age, 53.1 [11.9] years; 760 [57.8%] women), and 919 (69.8%) provided final follow-up. Intention-to-treat analyses showed 162 participants (12.3%) had biochemically confirmed abstinence at 26 weeks (368 [28.0% self-reported abstinence]). There were no significant main effects for the primary outcome: 1 call (11.6% [77 of 662]) vs 4 calls (13.0% [85 of 654]) (odds ratio [OR], 1.04; 95% CI, 0.88-1.24), 2-week patch (11.2% [73 of 654]) vs 4-week combination nicotine replacement therapy (13.4% [89 of 662]) (OR, 1.12; 95% CI, 0.94-1.34), no SmokefreeTXT (13.4% [88 of 657]) vs SmokefreeTXT (11.2% [74 of 659]) (OR, 0.88; 95% CI, 0.74-1.05), and no financial incentives (12.8% [85 of 662]) vs financial incentives (11.8% [77 of 654]) (OR, 0.94; 95% CI, 0.78-1.11).</p><p><strong>Conclusions and relevance: </strong>In this randomized clinical trial evaluating enhancements to tobacco quitlines for adults with socioeconomic disadvantage who were smoking after quitline treatment, none of the adaptive treatment strategies robustly improved long-term abstinence. Strategies are needed to enhance quitline retreatment effectiveness for adults with socioeconomic dis
重要性:单轮标准戒烟治疗可能不足以维持戒烟,尤其是在社会经济条件较差的人群中。适应性再治疗可以帮助更多社会经济条件较差的人实现戒烟,减少戒烟结果的差异:目的:评估针对教育程度有限、无保险或无医疗补助资格的成年人在接受戒烟治疗后继续吸烟的 4 种循证策略:对 2018 年 6 月 7 日至 2023 年 1 月 25 日期间注册的参与者进行了一项因子随机临床试验,对戒烟热线策略进行了 4 个因子的调整,并进行了 6 个月的随访。研究对象包括使用威斯康星州烟草戒烟热线的成人,他们在接受戒烟热线治疗 3 至 6 个月后仍在吸烟,且无保险、有医疗补助保险或学历不超过高中:戒烟热线再治疗策略包括:(1)增加咨询强度(4次呼叫 vs 1次呼叫);(2)增加尼古丁替代疗法强度(4周尼古丁贴片加尼古丁锭剂组合疗法 vs 2周尼古丁贴片疗法);(3)短信支持(美国国家癌症研究所SmokefreeTXT项目 vs 无);(4)对参与咨询和SmokefreeTXT给予经济奖励(30美元/次呼叫和/或保留6周SmokefreeTXT vs 无奖励):主要结果: 主要结果是目标戒烟日26周后7天的生化证实戒烟率。进行了意向治疗分析:在接受资格评估的 6019 人中,1316 人(21.9%)接受了随机治疗(平均 [SD] 年龄为 53.1 [11.9] 岁;760 [57.8%] 名女性),919 人(69.8%)接受了最终随访。意向治疗分析表明,162 名参与者(12.3%)在 26 周时经生化证实戒毒(368 人 [28.0% 自我报告戒毒])。主要结果没有明显的主效应:34),无SmokefreeTXT(13.4% [657中的88例]) vs SmokefreeTXT(11.2% [659中的74例])(OR,0.88;95% CI,0.74-1.05),以及无经济激励(12.8% [662中的85例]) vs 经济激励(11.8% [654中的77例])(OR,0.94;95% CI,0.78-1.11):在这项随机临床试验中,评估了针对社会经济条件较差、接受戒烟治疗后仍在吸烟的成年人的戒烟热线改进措施,结果发现没有一种适应性治疗策略能有效提高长期戒烟率。我们需要制定一些策略来提高针对社会经济条件较差的成年人的戒烟热线再治疗效果:试验注册:ClinicalTrials.gov Identifier:NCT03538938。
{"title":"Tobacco Quitline Retreatment Interventions Among Adults With Socioeconomic Disadvantage: A Factorial Randomized Clinical Trial.","authors":"Jesse T Kaye, Julie A Kirsch, Daniel M Bolt, Kathleen H Kobinsky, Katrina A Vickerman, Kristina Mullis, David L Fraser, Timothy B Baker, Michael C Fiore, Danielle E McCarthy","doi":"10.1001/jamanetworkopen.2024.43044","DOIUrl":"10.1001/jamanetworkopen.2024.43044","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Importance: &lt;/strong&gt;A single round of standard tobacco quitline treatment may not be sufficient to sustain abstinence, particularly among people experiencing socioeconomic disadvantage. Adaptive retreatment may help more individuals with socioeconomic disadvantage achieve abstinence and reduce disparities in smoking cessation outcomes.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To evaluate 4 evidence-based strategies for adults with limited education, no insurance, or Medicaid eligibility who continued smoking after quitline treatment.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design, setting, and participants: &lt;/strong&gt;A factorial randomized clinical trial with 4 factors adapting quitline strategies was conducted for participants enrolled from June 7, 2018, to January 25, 2023, with 6-month follow-up. Adults using the Wisconsin Tobacco Quit Line who were smoking cigarettes 3 to 6 months after prior quitline treatment who were uninsured, Medicaid insured, or had no more than a high school education were included.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Interventions: &lt;/strong&gt;Quitline retreatment strategies were (1) increased counseling intensity (4 calls vs 1 call), (2) increased nicotine replacement therapy intensity (4 weeks of combination nicotine patch plus nicotine lozenge vs 2 weeks of nicotine patch), (3) text-message support (National Cancer Institute SmokefreeTXT program vs none), and (4) financial incentives for engagement in counseling and SmokefreeTXT ($30/call and/or 6-week SmokefreeTXT retention vs no incentives).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main outcomes and measures: &lt;/strong&gt;Primary outcome was 7-day point-prevalence biochemically confirmed abstinence 26 weeks after the target quit day. Intention-to-treat analysis was performed.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Of 6019 people assessed for eligibility, 1316 (21.9%) participants were randomized (mean [SD] age, 53.1 [11.9] years; 760 [57.8%] women), and 919 (69.8%) provided final follow-up. Intention-to-treat analyses showed 162 participants (12.3%) had biochemically confirmed abstinence at 26 weeks (368 [28.0% self-reported abstinence]). There were no significant main effects for the primary outcome: 1 call (11.6% [77 of 662]) vs 4 calls (13.0% [85 of 654]) (odds ratio [OR], 1.04; 95% CI, 0.88-1.24), 2-week patch (11.2% [73 of 654]) vs 4-week combination nicotine replacement therapy (13.4% [89 of 662]) (OR, 1.12; 95% CI, 0.94-1.34), no SmokefreeTXT (13.4% [88 of 657]) vs SmokefreeTXT (11.2% [74 of 659]) (OR, 0.88; 95% CI, 0.74-1.05), and no financial incentives (12.8% [85 of 662]) vs financial incentives (11.8% [77 of 654]) (OR, 0.94; 95% CI, 0.78-1.11).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions and relevance: &lt;/strong&gt;In this randomized clinical trial evaluating enhancements to tobacco quitlines for adults with socioeconomic disadvantage who were smoking after quitline treatment, none of the adaptive treatment strategies robustly improved long-term abstinence. Strategies are needed to enhance quitline retreatment effectiveness for adults with socioeconomic dis","PeriodicalId":14694,"journal":{"name":"JAMA Network Open","volume":"7 11","pages":"e2443044"},"PeriodicalIF":10.5,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11541633/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142583232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Learned and Unlearned Lessons in Quality and Safety From Hospitals' COVID-19 Burdens. 医院 COVID-19 负担在质量和安全方面的经验教训。
IF 10.5 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-04 DOI: 10.1001/jamanetworkopen.2024.42944
Benjamin D Pollock, Subashnie Devkaran, Sean C Dowdy
{"title":"Learned and Unlearned Lessons in Quality and Safety From Hospitals' COVID-19 Burdens.","authors":"Benjamin D Pollock, Subashnie Devkaran, Sean C Dowdy","doi":"10.1001/jamanetworkopen.2024.42944","DOIUrl":"https://doi.org/10.1001/jamanetworkopen.2024.42944","url":null,"abstract":"","PeriodicalId":14694,"journal":{"name":"JAMA Network Open","volume":"7 11","pages":"e2442944"},"PeriodicalIF":10.5,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Guidelines for the Prevention, Diagnosis, and Management of Urinary Tract Infections in Pediatrics and Adults: A WikiGuidelines Group Consensus Statement. 儿科和成人尿路感染的预防、诊断和管理指南:维基指南小组共识声明》。
IF 10.5 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-04 DOI: 10.1001/jamanetworkopen.2024.44495
Zachary Nelson, Abdullah Tarik Aslan, Nathan P Beahm, Michelle Blyth, Matthew Cappiello, Danielle Casaus, Fernando Dominguez, Susan Egbert, Alexandra Hanretty, Tina Khadem, Katie Olney, Ahmed Abdul-Azim, Gloria Aggrey, Daniel T Anderson, Mariana Barosa, Michael Bosco, Elias B Chahine, Souradeep Chowdhury, Alyssa Christensen, Daniela de Lima Corvino, Margaret Fitzpatrick, Molly Fleece, Brent Footer, Emily Fox, Bassam Ghanem, Fergus Hamilton, Justin Hayes, Boris Jegorovic, Philipp Jent, Rodolfo Norberto Jimenez-Juarez, Annie Joseph, Minji Kang, Geena Kludjian, Sarah Kurz, Rachael A Lee, Todd C Lee, Timothy Li, Alberto Enrico Maraolo, Mira Maximos, Emily G McDonald, Dhara Mehta, Justin William Moore, Cynthia T Nguyen, Cihan Papan, Akshatha Ravindra, Brad Spellberg, Robert Taylor, Alexis Thumann, Steven Y C Tong, Michael Veve, James Wilson, Arsheena Yassin, Veronica Zafonte, Alfredo J Mena Lora

Importance: Traditional approaches to practice guidelines frequently result in dissociation between strength of recommendation and quality of evidence.

Objective: To create a clinical guideline for the diagnosis and management of urinary tract infections that addresses the gap between the evidence and recommendation strength.

Evidence review: This consensus statement and systematic review applied an approach previously established by the WikiGuidelines Group to construct collaborative clinical guidelines. In May 2023, new and existing members were solicited for questions on urinary tract infection prevention, diagnosis, and management. For each topic, literature searches were conducted up until early 2024 in any language. Evidence was reported according to the WikiGuidelines charter: clear recommendations were established only when reproducible, prospective, controlled studies provided hypothesis-confirming evidence. In the absence of such data, clinical reviews were developed discussing the available literature and associated risks and benefits of various approaches.

Findings: A total of 54 members representing 12 countries reviewed 914 articles and submitted information relevant to 5 sections: prophylaxis and prevention (7 questions), diagnosis and diagnostic stewardship (7 questions), empirical treatment (3 questions), definitive treatment and antimicrobial stewardship (10 questions), and special populations and genitourinary syndromes (10 questions). Of 37 unique questions, a clear recommendation could be provided for 6 questions. In 3 of the remaining questions, a clear recommendation could only be provided for certain aspects of the question. Clinical reviews were generated for the remaining questions and aspects of questions not meeting criteria for a clear recommendation.

Conclusions and relevance: In this consensus statement that applied the WikiGuidelines method for clinical guideline development, the majority of topics relating to prevention, diagnosis, and treatment of urinary tract infections lack high-quality prospective data and clear recommendations could not be made. Randomized clinical trials are underway to address some of these gaps; however further research is of utmost importance to inform true evidence-based, rather than eminence-based practice.

重要性:传统的实践指南常常导致推荐强度与证据质量之间的脱节:为尿路感染的诊断和管理制定临床指南,解决证据与推荐强度之间的差距:本共识声明和系统性回顾采用了 WikiGuidelines 小组之前制定的方法来构建合作性临床指南。2023 年 5 月,WikiGuidelines 小组向新老成员征集了有关尿路感染预防、诊断和管理的问题。针对每个主题,在 2024 年初之前以任何语言进行文献检索。根据 WikiGuidelines 章程对证据进行了报告:只有在可重复、前瞻性、对照研究提供了证实假设的证据时,才会提出明确的建议。在缺乏此类数据的情况下,则编写临床综述,讨论现有文献以及各种方法的相关风险和益处:代表 12 个国家的 54 名成员共审阅了 914 篇文章,并提交了与以下 5 个部分相关的信息:预防和预防(7 个问题)、诊断和诊断管理(7 个问题)、经验性治疗(3 个问题)、确定性治疗和抗菌药物管理(10 个问题)以及特殊人群和泌尿生殖系统综合征(10 个问题)。在 37 个独特的问题中,有 6 个问题可以提供明确的建议。在其余 3 个问题中,只能针对问题的某些方面提出明确的建议。对于其余问题和不符合明确推荐标准的问题的某些方面,我们生成了临床评论:在这份应用 WikiGuidelines 方法制定临床指南的共识声明中,大多数与尿路感染的预防、诊断和治疗相关的主题缺乏高质量的前瞻性数据,因此无法提出明确的建议。随机临床试验正在进行中,以弥补其中的一些不足;然而,进一步的研究对于提供真正的循证实践而非基于权威的实践至关重要。
{"title":"Guidelines for the Prevention, Diagnosis, and Management of Urinary Tract Infections in Pediatrics and Adults: A WikiGuidelines Group Consensus Statement.","authors":"Zachary Nelson, Abdullah Tarik Aslan, Nathan P Beahm, Michelle Blyth, Matthew Cappiello, Danielle Casaus, Fernando Dominguez, Susan Egbert, Alexandra Hanretty, Tina Khadem, Katie Olney, Ahmed Abdul-Azim, Gloria Aggrey, Daniel T Anderson, Mariana Barosa, Michael Bosco, Elias B Chahine, Souradeep Chowdhury, Alyssa Christensen, Daniela de Lima Corvino, Margaret Fitzpatrick, Molly Fleece, Brent Footer, Emily Fox, Bassam Ghanem, Fergus Hamilton, Justin Hayes, Boris Jegorovic, Philipp Jent, Rodolfo Norberto Jimenez-Juarez, Annie Joseph, Minji Kang, Geena Kludjian, Sarah Kurz, Rachael A Lee, Todd C Lee, Timothy Li, Alberto Enrico Maraolo, Mira Maximos, Emily G McDonald, Dhara Mehta, Justin William Moore, Cynthia T Nguyen, Cihan Papan, Akshatha Ravindra, Brad Spellberg, Robert Taylor, Alexis Thumann, Steven Y C Tong, Michael Veve, James Wilson, Arsheena Yassin, Veronica Zafonte, Alfredo J Mena Lora","doi":"10.1001/jamanetworkopen.2024.44495","DOIUrl":"10.1001/jamanetworkopen.2024.44495","url":null,"abstract":"<p><strong>Importance: </strong>Traditional approaches to practice guidelines frequently result in dissociation between strength of recommendation and quality of evidence.</p><p><strong>Objective: </strong>To create a clinical guideline for the diagnosis and management of urinary tract infections that addresses the gap between the evidence and recommendation strength.</p><p><strong>Evidence review: </strong>This consensus statement and systematic review applied an approach previously established by the WikiGuidelines Group to construct collaborative clinical guidelines. In May 2023, new and existing members were solicited for questions on urinary tract infection prevention, diagnosis, and management. For each topic, literature searches were conducted up until early 2024 in any language. Evidence was reported according to the WikiGuidelines charter: clear recommendations were established only when reproducible, prospective, controlled studies provided hypothesis-confirming evidence. In the absence of such data, clinical reviews were developed discussing the available literature and associated risks and benefits of various approaches.</p><p><strong>Findings: </strong>A total of 54 members representing 12 countries reviewed 914 articles and submitted information relevant to 5 sections: prophylaxis and prevention (7 questions), diagnosis and diagnostic stewardship (7 questions), empirical treatment (3 questions), definitive treatment and antimicrobial stewardship (10 questions), and special populations and genitourinary syndromes (10 questions). Of 37 unique questions, a clear recommendation could be provided for 6 questions. In 3 of the remaining questions, a clear recommendation could only be provided for certain aspects of the question. Clinical reviews were generated for the remaining questions and aspects of questions not meeting criteria for a clear recommendation.</p><p><strong>Conclusions and relevance: </strong>In this consensus statement that applied the WikiGuidelines method for clinical guideline development, the majority of topics relating to prevention, diagnosis, and treatment of urinary tract infections lack high-quality prospective data and clear recommendations could not be made. Randomized clinical trials are underway to address some of these gaps; however further research is of utmost importance to inform true evidence-based, rather than eminence-based practice.</p>","PeriodicalId":14694,"journal":{"name":"JAMA Network Open","volume":"7 11","pages":"e2444495"},"PeriodicalIF":10.5,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinician Distribution and Type in Rural and Urban Areas of the National Health Services Corps. 国家卫生服务团城乡地区临床医生的分布和类型。
IF 10.5 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-04 DOI: 10.1001/jamanetworkopen.2024.45995
Olesya Baker, Marcela Horvitz-Lennon, Hao Yu
{"title":"Clinician Distribution and Type in Rural and Urban Areas of the National Health Services Corps.","authors":"Olesya Baker, Marcela Horvitz-Lennon, Hao Yu","doi":"10.1001/jamanetworkopen.2024.45995","DOIUrl":"10.1001/jamanetworkopen.2024.45995","url":null,"abstract":"","PeriodicalId":14694,"journal":{"name":"JAMA Network Open","volume":"7 11","pages":"e2445995"},"PeriodicalIF":10.5,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142668129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends in Postpartum Depression by Race, Ethnicity, and Prepregnancy Body Mass Index. 按种族、族裔和孕前体重指数划分的产后抑郁症趋势。
IF 10.5 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-04 DOI: 10.1001/jamanetworkopen.2024.46486
Nehaa Khadka, Michael J Fassett, Yinka Oyelese, Nana A Mensah, Vicki Y Chiu, Meiyu Yeh, Morgan R Peltier, Darios Getahun

Importance: Postpartum depression (PPD) poses significant risks to maternal and child health. Understanding temporal trends is crucial for evaluating prevalence and identifying populations at risk.

Objective: To evaluate recent trends in PPD and assess how these trends are associated with race, ethnicity, and prepregnancy body mass index (BMI).

Design, setting, and participants: A serial, cross-sectional analysis using data from the Kaiser Permanente Southern California (KPSC) electronic health records (EHRs), with live and stillbirths at 20 or more weeks of gestation who were KPSC members at the time of delivery between 2010 and 2021. Data were analyzed from July 2022 to August 2023.

Exposures: Self-reported race, ethnicity, and recorded prepregnancy BMI.

Main outcome measures: PPD cases were identified using validated diagnostic codes and prescription records within 12 months postpartum in the KPSC EHRs. Patients with an Edinburgh Postnatal Depression Scale score of 10 or more within 6 months postpartum were further evaluated by a mental health specialist for formal PPD diagnosis.

Results: In this study of 442 308 pregnancies, the median (IQR) maternal age at delivery was 31 (27-34) years. The cohort was racially and ethnically diverse, with 62 860 individuals (14.2%) identifying as Asian/Pacific Islander, 231 837 (52.4%) as Hispanic, 33 207 (7.5%) as non-Hispanic Black, 108 201 (24.5%) as non-Hispanic White, 5903 (1.3%) as multiple or other, and 300 (0.1%) unknown. PPD prevalence doubled over the study period, increasing from 9.4% in 2010 to 19.0% in 2021. The largest increases were observed among Asian and Pacific Islander participants (280% increase) and non-Hispanic Black participants (140% increase). PPD rates increased across all BMI categories, particularly among individuals with obesity (class I) and morbid obesity (class II/III).

Conclusions and relevance: In this cross-sectional study, PPD diagnosis increased significantly across all racial and ethnic groups and BMI categories over the past decade. While rising PPD may reflect improved screening and diagnosis practices, the persistently high rates highlight the need to develop and implement interventions to prevent the condition while expanding efforts to mitigate the impact of PPD on maternal and child health.

重要性:产后抑郁症(PPD)对母婴健康构成重大风险。了解时间趋势对于评估患病率和确定高危人群至关重要:评估产后抑郁症的最新趋势,并评估这些趋势与种族、民族和孕前体重指数(BMI)的关系:利用南加州凯泽医疗集团(KPSC)电子健康记录(EHR)中的数据,对 2010 年至 2021 年间妊娠 20 周或 20 周以上、分娩时为 KPSC 会员的活产和死产进行连续横断面分析。数据分析时间为 2022 年 7 月至 2023 年 8 月:自我报告的种族、民族和记录的孕前体重指数:利用 KPSC 电子病历中经过验证的诊断代码和产后 12 个月内的处方记录确定 PPD 病例。产后 6 个月内爱丁堡产后抑郁量表评分达到或超过 10 分的患者将由心理健康专家进行进一步评估,以获得 PPD 的正式诊断:在这项包含 442 308 名孕妇的研究中,产妇的中位(IQR)分娩年龄为 31(27-34)岁。该群体具有种族和民族多样性,其中 62 860 人(14.2%)为亚洲/太平洋岛民,231 837 人(52.4%)为西班牙裔,33 207 人(7.5%)为非西班牙裔黑人,108 201 人(24.5%)为非西班牙裔白人,5903 人(1.3%)为多重或其他身份,300 人(0.1%)身份不明。在研究期间,PPD 患病率翻了一番,从 2010 年的 9.4% 增加到 2021 年的 19.0%。亚裔和太平洋岛民参与者(增长 280%)和非西班牙裔黑人参与者(增长 140%)的增长幅度最大。所有 BMI 类别的 PPD 率均有所上升,尤其是肥胖(I 级)和病态肥胖(II/III 级)人群:在这项横断面研究中,在过去十年中,所有种族和民族群体以及 BMI 类别中的 PPD 诊断率都显著上升。虽然 PPD 的上升可能反映了筛查和诊断方法的改进,但持续的高发病率凸显了制定和实施干预措施以预防该疾病的必要性,同时需要加大力度减轻 PPD 对孕产妇和儿童健康的影响。
{"title":"Trends in Postpartum Depression by Race, Ethnicity, and Prepregnancy Body Mass Index.","authors":"Nehaa Khadka, Michael J Fassett, Yinka Oyelese, Nana A Mensah, Vicki Y Chiu, Meiyu Yeh, Morgan R Peltier, Darios Getahun","doi":"10.1001/jamanetworkopen.2024.46486","DOIUrl":"10.1001/jamanetworkopen.2024.46486","url":null,"abstract":"<p><strong>Importance: </strong>Postpartum depression (PPD) poses significant risks to maternal and child health. Understanding temporal trends is crucial for evaluating prevalence and identifying populations at risk.</p><p><strong>Objective: </strong>To evaluate recent trends in PPD and assess how these trends are associated with race, ethnicity, and prepregnancy body mass index (BMI).</p><p><strong>Design, setting, and participants: </strong>A serial, cross-sectional analysis using data from the Kaiser Permanente Southern California (KPSC) electronic health records (EHRs), with live and stillbirths at 20 or more weeks of gestation who were KPSC members at the time of delivery between 2010 and 2021. Data were analyzed from July 2022 to August 2023.</p><p><strong>Exposures: </strong>Self-reported race, ethnicity, and recorded prepregnancy BMI.</p><p><strong>Main outcome measures: </strong>PPD cases were identified using validated diagnostic codes and prescription records within 12 months postpartum in the KPSC EHRs. Patients with an Edinburgh Postnatal Depression Scale score of 10 or more within 6 months postpartum were further evaluated by a mental health specialist for formal PPD diagnosis.</p><p><strong>Results: </strong>In this study of 442 308 pregnancies, the median (IQR) maternal age at delivery was 31 (27-34) years. The cohort was racially and ethnically diverse, with 62 860 individuals (14.2%) identifying as Asian/Pacific Islander, 231 837 (52.4%) as Hispanic, 33 207 (7.5%) as non-Hispanic Black, 108 201 (24.5%) as non-Hispanic White, 5903 (1.3%) as multiple or other, and 300 (0.1%) unknown. PPD prevalence doubled over the study period, increasing from 9.4% in 2010 to 19.0% in 2021. The largest increases were observed among Asian and Pacific Islander participants (280% increase) and non-Hispanic Black participants (140% increase). PPD rates increased across all BMI categories, particularly among individuals with obesity (class I) and morbid obesity (class II/III).</p><p><strong>Conclusions and relevance: </strong>In this cross-sectional study, PPD diagnosis increased significantly across all racial and ethnic groups and BMI categories over the past decade. While rising PPD may reflect improved screening and diagnosis practices, the persistently high rates highlight the need to develop and implement interventions to prevent the condition while expanding efforts to mitigate the impact of PPD on maternal and child health.</p>","PeriodicalId":14694,"journal":{"name":"JAMA Network Open","volume":"7 11","pages":"e2446486"},"PeriodicalIF":10.5,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142675837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prenatal Diet and Infant Growth From Birth to Age 24 Months. 产前饮食与婴儿从出生到 24 个月的生长发育。
IF 10.5 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-04 DOI: 10.1001/jamanetworkopen.2024.45771
Monique M Hedderson, Holly B Schuh, Emily A Knapp, Traci A Bekelman, Diane J Catellier, Matt Westlake, Kristen Lyall, Rebecca J Schmidt, Anne L Dunlop, Sarah S Comstock, Leda Chatzi, Katherine A Sauder, Dana Dabelea, Karen M Switkowski, Pi-I Debby Lin, Lyndsay A Avalos, Yeyi Zhu, Assiamira Ferrara
<p><strong>Importance: </strong>Being born either small for gestational age (SGA) or large for gestational age (LGA) and experiencing rapid or slow growth after birth are associated with later-life obesity. Understanding the associations of dietary quality during pregnancy with infant growth may inform obesity prevention strategies.</p><p><strong>Objective: </strong>To evaluate the associations of prenatal dietary quality according to the Healthy Eating Index (HEI) and the Empirical Dietary Inflammatory Pattern (EDIP) with infant size at birth and infant growth from birth to age 24 months.</p><p><strong>Design, setting, and participants: </strong>This cohort study used data from birthing parent-child dyads in 8 cohorts participating in the Environmental influences on Child Health Outcomes program between 2007 and 2021. Data were analyzed from March 2021 to August 2024.</p><p><strong>Exposures: </strong>The HEI and the EDIP dietary patterns.</p><p><strong>Main outcomes and measures: </strong>Outcomes of interest were infant birth weight, categorized as SGA, reference range, or LGA, and infant growth from birth to ages 6, 12, and 24 months, categorized as slow growth (weight-for-length z score [WLZ] score difference <-0.67), within reference range (WLZ score difference -0.67 to 0.67), or rapid (WLZ score difference, >0.67).</p><p><strong>Results: </strong>The study included 2854 birthing parent-child dyads (median [IQR] maternal age, 30 [25-34] years; 1464 [51.3%] male infants). The cohort was racially and ethnically diverse, including 225 Asian or Pacific Islander infants (7.9%), 640 Black infants (22.4%), 1022 Hispanic infants (35.8%), 664 White infants (23.3%), and 224 infants (7.8%) with other race or multiple races. A high HEI score (>80), indicative of a healthier diet, was associated with lower odds of LGA (adjusted odds ratio [aOR], 0.88 [95% CI, 0.79-0.98]), rapid growth from birth to age 6 months (aOR, 0.80 [95% CI, 0.37-0.94]) and age 24 months (aOR 0.82 [95% CI, 0.70- 0.96]), and slow growth from birth to age 6 months (aOR, 0.65 [95% CI, 0.50-0.84]), 12 months (aOR, 0.74 [95% CI, 0.65-0.83]), and 24 months (OR, 0.65 [95% CI, 0.56-0.76]) compared with an HEI score 80 or lower. There was no association between high HEI and SGA (aOR, 1.14 [95% CI, 0.95-1.35]). A low EDIP score (ie, ≤63.6), indicative of a less inflammatory diet, was associated with higher odds of LGA (aOR, 1.24 [95% CI, 1.13-1.36]) and rapid infant growth from birth to age 12 months (aOR, 1.50 [95% CI, 1.18-1.91]) and lower odds of rapid growth to age 6 months (aOR, 0.77 [95% CI, 0.71-0.83]), but there was no association with SGA (aOR, 0.80 [95% CI, 0.51-1.25]) compared with an EDIP score of 63.6 or greater.</p><p><strong>Conclusions and relevance: </strong>In this cohort study, a prenatal diet that aligned with the US Dietary Guidelines was associated with reduced patterns of rapid and slow infant growth, known risk factors associated with obesity. Future research should
重要性:出生时胎龄小 (SGA) 或胎龄大 (LGA),以及出生后生长速度快或慢都与日后肥胖有关。了解孕期饮食质量与婴儿生长的关系可为肥胖预防策略提供参考:目的:根据健康饮食指数(HEI)和经验性膳食炎症模式(EDIP)评估产前膳食质量与婴儿出生时体型以及婴儿从出生到 24 个月的生长发育之间的关系:这项队列研究使用的数据来自 2007 年至 2021 年间参加环境对儿童健康结果影响项目的 8 个队列中的分娩亲子二人组。数据分析时间为 2021 年 3 月至 2024 年 8 月:主要结果和测量指标:主要结果和测量指标:关注的结果是婴儿出生体重,分为 SGA、参考范围或 LGA,以及婴儿从出生到 6、12 和 24 个月的生长情况,分为生长缓慢(体重身长 z 评分 [WLZ] 分差为 0.67):该研究包括2854对分娩亲子(产妇年龄中位数[IQR]为30 [25-34]岁;1464 [51.3%]名男婴)。该群体具有种族和民族多样性,包括 225 名亚洲或太平洋岛民婴儿(7.9%)、640 名黑人婴儿(22.4%)、1022 名西班牙裔婴儿(35.8%)、664 名白人婴儿(23.3%)以及 224 名其他种族或多种种族婴儿(7.8%)。HEI 得分高(>80 分)表明饮食更健康,与 LGA(调整后的几率比 [aOR],0.88 [95% CI,0.79-0.98])、出生至 6 个月大快速生长(aOR,0.80 [95% CI,0.37-0.94])和 24 个月大快速生长(aOR 0.82[95%CI,0.70- 0.96]),以及出生至 6 个月(aOR,0.65 [95% CI,0.50-0.84])、12 个月(aOR,0.74 [95% CI,0.65-0.83])和 24 个月(OR,0.65 [95% CI,0.56-0.76])期间生长缓慢。高 HEI 与 SGA 之间没有关联(aOR,1.14 [95% CI,0.95-1.35])。低 EDIP 得分(即≤63.6)表明饮食中的炎症较少,与较高的 LGA 机率(aOR,1.24 [95% CI,1.13-1.36])和婴儿从出生到 12 个月的快速生长(aOR,1.50 [95% CI,1.18-1.91])相关,而与较低的快速生长机率(aOR,1.14 [95% CI,0.95-1.35])相关。91])和 6 个月时快速生长的几率较低(aOR,0.77 [95% CI,0.71-0.83]),但与 EDIP 评分为 63.6 或更高相比,与 SGA 没有关联(aOR,0.80 [95% CI,0.51-1.25]):在这项队列研究中,符合《美国膳食指南》的产前饮食与婴儿生长过快和过慢模式的减少有关,而婴儿生长过快和过慢是与肥胖有关的已知风险因素。未来的研究应探讨改善产前饮食的干预措施是否也有利于改善儿童的生长轨迹。
{"title":"Prenatal Diet and Infant Growth From Birth to Age 24 Months.","authors":"Monique M Hedderson, Holly B Schuh, Emily A Knapp, Traci A Bekelman, Diane J Catellier, Matt Westlake, Kristen Lyall, Rebecca J Schmidt, Anne L Dunlop, Sarah S Comstock, Leda Chatzi, Katherine A Sauder, Dana Dabelea, Karen M Switkowski, Pi-I Debby Lin, Lyndsay A Avalos, Yeyi Zhu, Assiamira Ferrara","doi":"10.1001/jamanetworkopen.2024.45771","DOIUrl":"https://doi.org/10.1001/jamanetworkopen.2024.45771","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Importance: &lt;/strong&gt;Being born either small for gestational age (SGA) or large for gestational age (LGA) and experiencing rapid or slow growth after birth are associated with later-life obesity. Understanding the associations of dietary quality during pregnancy with infant growth may inform obesity prevention strategies.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To evaluate the associations of prenatal dietary quality according to the Healthy Eating Index (HEI) and the Empirical Dietary Inflammatory Pattern (EDIP) with infant size at birth and infant growth from birth to age 24 months.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design, setting, and participants: &lt;/strong&gt;This cohort study used data from birthing parent-child dyads in 8 cohorts participating in the Environmental influences on Child Health Outcomes program between 2007 and 2021. Data were analyzed from March 2021 to August 2024.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Exposures: &lt;/strong&gt;The HEI and the EDIP dietary patterns.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main outcomes and measures: &lt;/strong&gt;Outcomes of interest were infant birth weight, categorized as SGA, reference range, or LGA, and infant growth from birth to ages 6, 12, and 24 months, categorized as slow growth (weight-for-length z score [WLZ] score difference &lt;-0.67), within reference range (WLZ score difference -0.67 to 0.67), or rapid (WLZ score difference, &gt;0.67).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The study included 2854 birthing parent-child dyads (median [IQR] maternal age, 30 [25-34] years; 1464 [51.3%] male infants). The cohort was racially and ethnically diverse, including 225 Asian or Pacific Islander infants (7.9%), 640 Black infants (22.4%), 1022 Hispanic infants (35.8%), 664 White infants (23.3%), and 224 infants (7.8%) with other race or multiple races. A high HEI score (&gt;80), indicative of a healthier diet, was associated with lower odds of LGA (adjusted odds ratio [aOR], 0.88 [95% CI, 0.79-0.98]), rapid growth from birth to age 6 months (aOR, 0.80 [95% CI, 0.37-0.94]) and age 24 months (aOR 0.82 [95% CI, 0.70- 0.96]), and slow growth from birth to age 6 months (aOR, 0.65 [95% CI, 0.50-0.84]), 12 months (aOR, 0.74 [95% CI, 0.65-0.83]), and 24 months (OR, 0.65 [95% CI, 0.56-0.76]) compared with an HEI score 80 or lower. There was no association between high HEI and SGA (aOR, 1.14 [95% CI, 0.95-1.35]). A low EDIP score (ie, ≤63.6), indicative of a less inflammatory diet, was associated with higher odds of LGA (aOR, 1.24 [95% CI, 1.13-1.36]) and rapid infant growth from birth to age 12 months (aOR, 1.50 [95% CI, 1.18-1.91]) and lower odds of rapid growth to age 6 months (aOR, 0.77 [95% CI, 0.71-0.83]), but there was no association with SGA (aOR, 0.80 [95% CI, 0.51-1.25]) compared with an EDIP score of 63.6 or greater.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions and relevance: &lt;/strong&gt;In this cohort study, a prenatal diet that aligned with the US Dietary Guidelines was associated with reduced patterns of rapid and slow infant growth, known risk factors associated with obesity. Future research should ","PeriodicalId":14694,"journal":{"name":"JAMA Network Open","volume":"7 11","pages":"e2445771"},"PeriodicalIF":10.5,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142681934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Timing of Neonatal Discharge and Unplanned Readmission to PICUs Among Infants Born Preterm. 早产儿中新生儿出院时间和再次入住 PICU 的计划外情况。
IF 10.5 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-04 DOI: 10.1001/jamanetworkopen.2024.44909
Tim J van Hasselt, Yuhe Wang, Chris Gale, Shalini Ojha, Cheryl Battersby, Peter Davis, Hari Krishnan Kanthimathinathan, Elizabeth S Draper, Sarah E Seaton
<p><strong>Importance: </strong>Children born very preterm (<32 weeks) are at risk of ongoing morbidity and admission to pediatric intensive care units (PICUs) in childhood. However, the influence of the timing of neonatal discharge on unplanned PICU admission has not been established.</p><p><strong>Objective: </strong>To examine whether the timing of neonatal discharge (postmenstrual age and season) is associated with subsequent unplanned PICU admission.</p><p><strong>Design, setting, and participants: </strong>This retrospective cohort study used linked national data from the National Neonatal Research Database and Paediatric Intensive Care Audit Network (PICANet) for children born from January 2013 to December 2018 at 22 to 31 weeks' gestational age who were admitted to a neonatal unit in England and Wales and were discharged home at 34 weeks' postmenstrual age or later. All National Health Service (NHS) neonatal units and PICUs in England and Wales were included. Children were followed up until 2 years of chronological age. Data analysis was conducted from October 2023 to August 2024.</p><p><strong>Exposures: </strong>Timing of discharge.</p><p><strong>Main outcomes and measures: </strong>The primary outcome was unplanned PICU admission between neonatal discharge and chronological age 2 years to any PICU within England and Wales. Survival analysis using a flexible parametric model was conducted with season of discharge (time-dependent factor), gestation, sex, birth weight less than the 10th centile, bronchopulmonary dysplasia, necrotizing enterocolitis, brain injury, and earlier neonatal discharge (lower quartile of postmenstrual age at discharge for gestation) as variables.</p><p><strong>Results: </strong>Of 39 938 children discharged home (median [IQR] gestational age, 29 [27-31] weeks; 21 602 [54.1%] male), 1878 (4.7%) had unplanned PICU admission. More than half of admissions occurred within 50 days of neonatal discharge (1080 [57.5%]). Compared with summer, the risk of unplanned PICU admission following neonatal discharge was 2.58 times higher in winter and 2.35 times higher in autumn (winter: adjusted hazard ratio [aHR], 2.58; 95% CI, 1.68-3.95; autumn: aHR, 2.35; 95% CI, 1.84-2.99). Among children born at 28 to 31 weeks' gestational age, earlier neonatal discharge was associated with increased risk (aHR, 1.30; 95% CI, 1.13-1.49), but this was not true for children born younger than 28 weeks' gestational age.</p><p><strong>Conclusions and relevance: </strong>In this retrospective cohort study of preterm children, autumn and winter discharge were associated with the highest risk of unplanned PICU admission following neonatal discharge. For children born at 28 to 31 weeks' gestational age, discharge at lower postmenstrual age was also associated with increased risk. Further work is required to understand whether delaying neonatal discharge for some children born at 28 to 31 weeks' gestational age is beneficial and to consider the wider co
重要性:早产儿(目的:研究新生儿出院时间(月经后年龄和季节)是否与随后的非计划 PICU 入院有关:研究新生儿出院时间(月经后年龄和季节)是否与随后的非计划 PICU 入院有关:这项回顾性队列研究使用了国家新生儿研究数据库(National Neonatal Research Database)和儿科重症监护审核网络(PICANet)的相关国家数据,研究对象为 2013 年 1 月至 2018 年 12 月期间出生、胎龄 22 至 31 周、入住英格兰和威尔士新生儿病房、月经后 34 周或更晚出院回家的儿童。研究对象包括英格兰和威尔士的所有国民健康服务(NHS)新生儿病房和PICU。对患儿进行随访,直至其年满 2 周岁。数据分析时间为2023年10月至2024年8月:主要结果和测量指标:主要结果是新生儿出院至2岁时,在英格兰和威尔士境内的任何PICU中的非计划PICU入院情况。使用灵活的参数模型进行了生存分析,并将出院季节(时间依赖因素)、孕期、性别、出生体重小于第 10 百分位数、支气管肺发育不良、坏死性小肠结肠炎、脑损伤和新生儿出院时间较早(出院时月经后年龄的较低四分位数为孕期)作为变量:在 39 938 名出院回家的儿童中(中位数[IQR]胎龄为 29 [27-31] 周;21 602 [54.1%] 名男性),有 1878 名儿童(4.7%)在计划外入住了 PICU。一半以上的入院时间发生在新生儿出院后 50 天内(1080 [57.5%])。与夏季相比,冬季和秋季新生儿出院后意外入住 PICU 的风险分别高出 2.58 倍和 2.35 倍(冬季:调整后危险比 [aHR],2.58;95% CI,1.68-3.95;秋季:aHR,2.35;95% CI,1.84-2.99)。在胎龄为 28 至 31 周的新生儿中,较早出院与风险增加有关(aHR,1.30;95% CI,1.13-1.49),但在胎龄小于 28 周的新生儿中情况并非如此:在这项早产儿回顾性队列研究中,秋季和冬季出院与新生儿出院后意外入住 PICU 的最高风险相关。对于胎龄在 28 至 31 周的新生儿,在月经后较低年龄出院也与风险增加有关。我们还需要进一步研究,以了解对某些胎龄在28周至31周的新生儿延迟出院是否有益,并考虑延长新生儿护理的更广泛成本和影响。
{"title":"Timing of Neonatal Discharge and Unplanned Readmission to PICUs Among Infants Born Preterm.","authors":"Tim J van Hasselt, Yuhe Wang, Chris Gale, Shalini Ojha, Cheryl Battersby, Peter Davis, Hari Krishnan Kanthimathinathan, Elizabeth S Draper, Sarah E Seaton","doi":"10.1001/jamanetworkopen.2024.44909","DOIUrl":"10.1001/jamanetworkopen.2024.44909","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Importance: &lt;/strong&gt;Children born very preterm (&lt;32 weeks) are at risk of ongoing morbidity and admission to pediatric intensive care units (PICUs) in childhood. However, the influence of the timing of neonatal discharge on unplanned PICU admission has not been established.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To examine whether the timing of neonatal discharge (postmenstrual age and season) is associated with subsequent unplanned PICU admission.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design, setting, and participants: &lt;/strong&gt;This retrospective cohort study used linked national data from the National Neonatal Research Database and Paediatric Intensive Care Audit Network (PICANet) for children born from January 2013 to December 2018 at 22 to 31 weeks' gestational age who were admitted to a neonatal unit in England and Wales and were discharged home at 34 weeks' postmenstrual age or later. All National Health Service (NHS) neonatal units and PICUs in England and Wales were included. Children were followed up until 2 years of chronological age. Data analysis was conducted from October 2023 to August 2024.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Exposures: &lt;/strong&gt;Timing of discharge.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main outcomes and measures: &lt;/strong&gt;The primary outcome was unplanned PICU admission between neonatal discharge and chronological age 2 years to any PICU within England and Wales. Survival analysis using a flexible parametric model was conducted with season of discharge (time-dependent factor), gestation, sex, birth weight less than the 10th centile, bronchopulmonary dysplasia, necrotizing enterocolitis, brain injury, and earlier neonatal discharge (lower quartile of postmenstrual age at discharge for gestation) as variables.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Of 39 938 children discharged home (median [IQR] gestational age, 29 [27-31] weeks; 21 602 [54.1%] male), 1878 (4.7%) had unplanned PICU admission. More than half of admissions occurred within 50 days of neonatal discharge (1080 [57.5%]). Compared with summer, the risk of unplanned PICU admission following neonatal discharge was 2.58 times higher in winter and 2.35 times higher in autumn (winter: adjusted hazard ratio [aHR], 2.58; 95% CI, 1.68-3.95; autumn: aHR, 2.35; 95% CI, 1.84-2.99). Among children born at 28 to 31 weeks' gestational age, earlier neonatal discharge was associated with increased risk (aHR, 1.30; 95% CI, 1.13-1.49), but this was not true for children born younger than 28 weeks' gestational age.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions and relevance: &lt;/strong&gt;In this retrospective cohort study of preterm children, autumn and winter discharge were associated with the highest risk of unplanned PICU admission following neonatal discharge. For children born at 28 to 31 weeks' gestational age, discharge at lower postmenstrual age was also associated with increased risk. Further work is required to understand whether delaying neonatal discharge for some children born at 28 to 31 weeks' gestational age is beneficial and to consider the wider co","PeriodicalId":14694,"journal":{"name":"JAMA Network Open","volume":"7 11","pages":"e2444909"},"PeriodicalIF":10.5,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11565260/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142619613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JAMA Network Open
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1